Skip to Content

N 412 200 (Fenofibrate (Micronized) 200 mg)

Pill with imprint N 412 200 is Orange, Capsule-shape and has been identified as Fenofibrate (Micronized) 200 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N 412 200

Fenofibrate (Micronized)

Imprint
N 412 200
Strength
200 mg
Color
Orange
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc
National Drug Code (NDC)
00093-8012

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.